🇺🇸 Lignospan Forte in United States

FDA authorised Lignospan Forte on 31 July 1984

Marketing authorisations

FDA — authorised 31 July 1984

  • Application: ANDA088368
  • Marketing authorisation holder: HOSPIRA
  • Local brand name: LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 31 July 1984

  • Application: ANDA088299
  • Marketing authorisation holder: HOSPIRA
  • Local brand name: LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 31 July 1984

  • Application: ANDA088325
  • Marketing authorisation holder: HOSPIRA
  • Local brand name: LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 31 July 1984

  • Application: ANDA088326
  • Marketing authorisation holder: HOSPIRA
  • Local brand name: LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 31 July 1984

  • Application: ANDA088327
  • Marketing authorisation holder: HOSPIRA
  • Local brand name: LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 31 July 1984

  • Application: ANDA088367
  • Marketing authorisation holder: HOSPIRA
  • Local brand name: LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 24 July 1985

  • Application: ANDA088586
  • Marketing authorisation holder: FRESENIUS KABI USA
  • Local brand name: LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

Lignospan Forte in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Lignospan Forte approved in United States?

Yes. FDA authorised it on 31 July 1984; FDA authorised it on 31 July 1984; FDA authorised it on 31 July 1984.

Who is the marketing authorisation holder for Lignospan Forte in United States?

HOSPIRA holds the US marketing authorisation.